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LanthanumDifferent studies have reported that proteins involved in Ca2+ entry are localized in discrete plasma
membrane domains known as lipid rafts, which have been suggested to support store-operated Ca2+ entry
by facilitating STIM1 clustering in endoplasmic reticulum–plasma membrane junctions as well as the
interaction of STIM1 with TRPC1. Here we report that treatment of HEK293 cells with thapsigargin (TG)
results in the activation of Ca2+ entry with two components, an early, La3+-sensitive, component and a late
component that shows both La3+-sensitive and -insensitive constituents. Preincubation with methyl-β-
cyclodextrin (MβCD) prevented TG-induced activation of Ca2+ entry but, in contrast, enhanced this process
after its activation. Addition of MβCD after store depletion did not modify the La3+-sensitive store-operated
divalent cation entry but increased La3+-insensitive non-capacitative Ca2+ entry. Cell stimulation with TG
results in a transient increase in Orai1 co-immunoprecipitation with STIM1, TRPC1 and TRPC6. TG-induced
association of these proteins was signiﬁcantly attenuated by preincubation for 30 min with MβCD, without
altering surface expression of Orai1 or TRPCs. In contrast, the association of Orai1 with STIM1 or TRPC1 was
unaffected when MβCD was added after store depletion with TG. Addition of MβCD to TG-treated cells
promoted dissociation between Orai1 and TRPC6, as well as non-capacitative Ca2+ entry. TRPC6 expression
silencing indicates that MβCD-enhanced non-capacitative Ca2+ entry was mediated by TRPC6. In conclusion,
lipid raft domains are necessary for the activation but not the maintenance of SOCE probably due to the
support of the formation of Ca2+ signalling complexes involving Orai1, TRPCs and STIM1.centration; BSA, bovine serum
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Store-operated or capacitative Ca2+ entry is a major mechanism
for Ca2+ inﬂux in non-electrically excitable cells [1], where it has been
reported to play an important role in Ca2+ signalling and intracellular
homeostasis under physiological conditions, including the support of
Ca2+ oscillations [2]. Store-operated Ca2+ entry (SOCE) is a
mechanism regulated by the ﬁlling state of the intracellular Ca2+
stores, which gates Ca2+ permeable channels in the plasma
membrane. As previously mentioned [3], SOCE can be temporally
divided into three components: an early component, which corre-sponds to its activation, the maintenance of Ca2+ inﬂux and a late
component leading to the inactivation of the process once the Ca2+
stores had been reﬁlled. Recent studies have provided evidence
supporting a role for the stromal interaction molecule (STIM) 1 as the
transmembrane endoplasmic reticulum (ER) Ca2+ sensor [4–7].
However, the nature of the plasma membrane Ca2+ permeable
channels involved in SOCE, as well as the mechanism of activation is
still unclear, with studies presenting Orai1 as a putative Ca2+ release-
activated Ca2+ current (CRAC) channel [8–13] and transient receptor
potential (TRP) proteins as candidates to mediate both SOCE and non-
capacitative Ca2+ entry [14–19]. Both Orai1 and TRP proteins have
been shown to participate in signalling complexes, including STIM1,
that play a relevant role in the activation of SOCE [18,20–22].
The reason of the current discrepancies concerning SOCE might
reside in themanoeuvres used to deplete the intracellular Ca2+ stores.
The most widely usedmeans to induce Ca2+ store depletion is the use
of SERCA blockers, such as thapsigargin (TG), which induce a passive
discharge of the stores that is variable depending on the Ca2+ leakage
rate of the Ca2+ compartment and the amount of Ca2+ accumulated
[23,24]. However, SERCA inhibitors cause a rise in cytosolic Ca2+
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[Ca2+]c elevation might be able to open Ca2+-activated cation
permeable channels leading to secondary, non-capacitative in nature,
Ca2+ inﬂux [25].
Store-operated Ca2+ entry has been shown to be modulated by
plasma membrane microdomains known as lipid rafts, plasma mem-
brane domains enriched in cholesterol and sphingolipids that facilitate
the recruitment of a number of signalling molecules [26]. Disruption of
lipid rafts by sequestrationofmembrane cholesterol has been reported to
reduce clustering of STIM1 into ER–plasma membrane junctions, the
association between STIM1, Orai1 and TRPC1 proteins, and the activation
stage of SOCE [27,28]. However, whether lipid rafts are important for the
maintenance of SOCE has not been investigated.
In the present study we sought to shed new light on the
understanding of the role of lipid rafts in SOCE. We describe for the
ﬁrst time that sequestration of cholesterol in store-depleted cells results
in enhancement of Ca2+ entry, most likely due to an increase in non-
capacitative Ca2+ entry, and results in dissociation of TRPC6 from the
Orai1protein,which strongly suggest that lipid rafts are important for the
regulation of TRPC6 function. In addition, we have found that lipid rafts
are important for the activation but not for the maintenance of SOCE.2. Materials and methods
2.1. Materials
TG, leupeptine, benzamidine, phenyl methyl sulphonyl ﬂuoride,
bovine serum albumin (BSA), lanthanum chloride, methyl-β-cyclodex-
trin (MβCD), anti-G actin antibody and anti-Orai1 antibody (C-terminal)
were from Sigma (St. Louis, MO, USA). Anti-hTRPC1 (C-terminal)
antibody was from Abcam (Cambridge, UK). Anti-hTRPC6 (C-terminal)
antibody and horseradish peroxidase-conjugated goat anti-rabbit IgG
antibody were from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Anti-STIM1 antibody was from BD (San Jose, CA, USA). Horseradish
peroxidase-conjugated ovine anti-mouse IgG antibody (NA931) and ECL
were from Amersham (Buckinghamshire, UK). Fura 2-AM was from
Invitrogen (Carlsbad, CA, USA). Enhanced chemiluminescence detection
reagents, immobilized streptavidin gel, and EZ-Link™ Sulfo-NHS-LC-
Biotin were from Pierce (Rockford, IL, USA). Cholesterol E test was from
Wako Diagnostics (Richmond, VA, USA). All other reagents were of
analytical grade.2.2. Cell culture and transfection
Human embryonic kidney 293 (HEK293) cells were obtained from
the American Type Culture Collection and cultured in Dulbecco's
modiﬁed Eagle's medium, supplemented with 10% heat-inactivated
fetal bovine serum, in a 37 °C incubator with 5% CO2. At the time of the
experiments cells were suspended in HEPES-buffered saline (HBS)
containing (in mM): 145 NaCl, 10 HEPES, 10 D-glucose, 5 KCl, 1 MgSO4,
1 mM CaCl2, pH 7.45. When a Ca2+-free medium was required 1.2 mM
EGTA was added.
Cell transfection with shTRPC1 and shTRPC6 was performed as
described previously [29,30] using shTRPC1 and shTRPC6 kindly
provided by Dr. Ambudkar. For the shRNA targeting human TRPC1 the
sense sequence was 5′-CACCGGGTGACTTTATATGGTTCGAAAACCATA-
TAATAGTCACCC-3′ and the antisense sequence was 5′-AAAAGGGT-
GACTATTATATGGTTTTCGAACCATATAATAGTCACCC-3′. For the
shTRPC6 the sense sequence was 5′-CACCGTCGAGGACCAGCATA-
CATGCGAACATGTATGCTGGTCCTCGAC-3′ and the antisense sequence
w a s 5 ′ - A AAAGT CGAGGAC CAGCA TACA TG T T CGCA TG -
TATGCTGGTCCTCGAC-3′. These sequences were synthesised and
hybridized as previously described [29,31]. Plasmids were used for
silencing experiments at the concentration 1 μg/μL.2.3. Immunoprecipitation
Cell suspension aliquots (500 μL) were treated as described and
lysed with lysis buffer, pH 7.2, containing 316 mM NaCl, 20 mM Tris,
2 mM EGTA, 0.2% SDS, 2% sodium deoxycholate, 2% triton X-100,
2 mM phenyl methyl sulfonyl ﬂuoride, 100 μg/mL leupeptin and
10 mM benzamidine. Protein immunoprecipitation was achieved by
incubating samples with 1 μg anti-STIM1 or anti-TRPC6 antibody or
2 μg anti-TRPC1 or anti-Orai1 antibody and protein A–agarose
overnight at 4 °C.
2.4. Western blotting
Western blotting was performed as described previously [32].
Brieﬂy, proteins were separated by 10% SDS-PAGE and electrophoret-
ically transferred, for 2 h at 0.8 mA/cm2, in a semi-dry blotter (Hoefer
Scientiﬁc, Newcastle, Staffs, UK) onto nitrocellulose membranes for
subsequent probing. Blots were incubated overnight with 10% (w/v)
BSA in Tris-buffered saline with 0.1% Tween 20 (TBST) to block residual
protein binding sites. Immunodetection of Orai1, hTRPC1, hTRPC6 and
STIM1was achieved using the anti-Orai1 or anti-STIM1antibodydiluted
1:250 in TBST for 2 h or the anti-hTRPC1 or anti-TRPC6 antibody diluted
1:200 in TBST for 2 h. To detect the primary antibody, blots were
incubated for 1 h with the appropriate horseradish peroxidase-
conjugated anti-IgG antibody diluted 1:10000 in TBST and then exposed
to enhanced chemiluminescence reagents for 4 min. Blots were then
exposed to photographic ﬁlms. The density of bands on the ﬁlm was
measured using a scanning densitometry.
2.5. Measurement of intracellular free calcium concentration ([Ca2+]c)
Cells were loaded with fura-2 by incubation with 2 μM fura-2/AM
for 30 min at room temperature. Fluorescence was recorded from
2 mL aliquots of magnetically stirred cellular suspension
(2×106 cells/mL) at 37 °C using a Cary Eclipse Spectrophotometer
(Varian Ltd, Madrid, Spain) with excitation wavelengths of 340 and
380 nm and emission at 505 nm. Changes in [Ca2+]c were monitored
using the fura-2 340/380 ﬂuorescence ratio and calibrated as
previously described [33].
Ca2+ release by TG was estimated using the integral of the rise in
[Ca2+]c for 180 s after the addition of the agonist [24]. Ca2+ entry was
estimated using the integral of the rise in [Ca2+]c for 150 s after
addition of CaCl2 and expressed as (nM⋅s) [34]. Ca2+ entry was
corrected by subtraction of the [Ca2+]c elevation due to leakage of the
indicator.
Mn2+ inﬂux was monitored as a quenching of fura-2 ﬂuorescence
at the isoemissive wavelength of 360 nm. To estimate the rate of fura-
2 ﬂuorescence quenching after the addition of Mn2+ to the medium
(or after addition of TG in the presence of Mn2+) the traces were ﬁtted
to the equation y=S×e−Kx+A, where K is the slope, S is the span and
A is the plateau [35].
2.6. Measurement of cholesterol levels
Quantitative determination of total cholesterolwas performed using
a previously described procedure [36]. HEK 293 cells (107 cells/200 μL
of phosphate-buffered saline (PBS) containing 137 mM NaCl, 2.7 mM
KCl, 5.62 mM Na2HPO4, 1.09 mM NaH2PO4, 1.47 mM KH2PO4, pH 7.2,
and supplemented with 0.5% (w/v) BSA) were lysed and cholesterol
was extracted from cell lysates by adding chloroform (400 μL) and
methanol (400 μL) to the sonicated cell lysate (100 μL). The bottom
(chloroform) layer was collected and evaporated under vacuum and
cholesterol was dissolved in ethanol and assayed using the colorimetric
assay Cholesterol E test (Wako Diagnostics), with absorbance deter-
mined at 600 nm in a spectrophotometer.
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CLMwas prepared as described previously [37,38]. Brieﬂy, 100 μmol
of MβCD were dissolved in 600 μL of methanol and mixed with
30.8 μmol of cholesterol. Themixturewas dried by nitrogen followed by
high vacuum for at least 1 h and then dispersed in 2 mL of PBS. The
resulting solutionwas sonicated for 3 min, incubated in a shaker at 37 °C
overnight and ﬁltered with a 0.22-μm-pore size syringe ﬁlter.
2.8. Biotinylation of cell surface proteins
Aliquots of cell suspensions (1 mL) were treated in the absence or
presence of MβCD following the indicated protocols. The reaction was
terminated with ice-cold Söerscen's buffer (SB) containing 16 mM
Na2HPO4, 114 mM NaH2PO4, pH 8.0. Cells were collected by
centrifugation at 900×g for 13 min at 4 °C. Cell surface proteins
were labeled by resuspending in EZ-Link™ Sulfo-NHS-LC-Biotin
(2.5 mg/12 mL of ice-cold SB) and incubated under mixing for 1 h
at 4 °C. The biotinylation reaction was terminated by the addition of
100 μL of 1 M Tris base, and remaining biotinylating agent was
removed by washing the cells in ice-cold SB. Labeled cells were
resuspended in PBS and then lysed. Labeled proteins were collected
by rotating the lysate overnight with streptavidin-coated agarose
beads and subjected to Western blotting as described previously.
2.9. Statistical analysis
Analysis of statistical signiﬁcance was performed using Student's t
test. The difference was considered statistically signiﬁcant when at least
pb0.05.
3. Results
3.1. Disruption of lipid rafts inhibits TG-induced activation of cation
entry
We have investigated the role of lipid rafts in the activation and
maintenance of TG-evoked Ca2+ entry by using two previously
described experimental manoeuvres [3,39]. The activation of Ca2+
entry was investigated by preincubation with MβCD, a compound
widely utilized to remove cholesterol from cells, thus disrupting the
lipid raft domains [26,27], prior to stimulation with TG. On the other
hand, MβCD was added after stimulation with TG when the role of
lipid rafts on the maintenance of Ca2+ entry was investigated.
In the absence of extracellular Ca2+, addition of TG (1 μM) to fura
2-loaded HEK293 cells in stirred cuvettes at 37 °C evoked a biphasic
elevation in [Ca2+]c due to release of Ca2+ from internal stores
consisting of an initial rapid and transient increase in [Ca2+]c,
followed by a sustained elevation in [Ca2+]c (Fig. 1A and B). We
have recently found that this response might be attributed to the
existence of at least two different Ca2+ pools in these cells, with
different Ca2+ leakage rates (Aulestia F, personal communication).
Subsequent addition of Ca2+ (ﬁnal concentration 2 mM) to the
external medium induced a sustained increase in [Ca2+]c indicative of
Ca2+ entry (Fig. 1A).
Cell treatment with 10 mM MβCD reduced the levels of cellular
cholesterol by 82% compared to levels found in control untreated cells
(Fig. 1E; n=4). Pretreatment of HEK293 cells at 37 °C with MβCD
(10 mM) for 30 min reduced TG-evoked Ca2+ entry to 80% of control.
MβCD-treated cells showed a similar release of Ca2+ from the
intracellular stores upon treatment with TG for 180 s as compared
to untreated cells, indicating that accumulation of Ca2+ in the internal
stores was not signiﬁcantly affected by disruption of lipid rafts
(Fig. 1A).
The effect of MβCD on TG-induced store-operated divalent cation
entry was conﬁrmed by monitoring the inﬂux of Mn2+, which can beused as a surrogate for Ca2+ entry given its quenching effect on fura-2
ﬂuorescence [40].
Fura-2 was excited at the isoemissive wavelength, 360 nm, to allow
monitoring of quenching of ﬂuorescence by Mn2+. In the presence of
Mn2+, treatment with TG resulted in a sustained quenching of fura-2
ﬂuorescence compared with non-stimulated cells (Table 1). Pretreat-
ment with MβCD had no effect on Mn2+ entry per se and reduced TG-
evoked Mn2+ inﬂux to 68% (Table 1).
3.2. Effect of MβCD on pre-activated store-operated Ca2+ entry
We have further investigated whether the integrity of the lipid raft
domains is required for the maintenance of Ca2+ entry. To explore this
issue we investigated the effect of MβCD on Ca2+ inﬂux in HEK293 cells
once SOCE had been stimulated by treatment with TG, as described
above. Fig. 1B shows the effect of addition ofMβCD toTG-treatedHEK293
cells.MβCD (10 mM)or the vehicle (DMSO)was added180 s after TG. As
shown in Fig. 1A, Ca2+ entry was clearly stimulated at this point in time.
Subsequent addition of MβCD for 30 min enhanced SOCE to 197% of
control, without altering the release of Ca2+ from the stores (Fig. 1B;
n=6). Theseﬁndings suggest that lipid rafts disruption in store-depleted
cells alters the maintenance of TG-evoked Ca2+ entry.
In order to investigate whether the effects of MβCD were speciﬁc
for cholesterol depletion, we performed a series of experimentswhere
cell were treated with CLM. As shown in Fig. 1C and D, treatment of
HEK 293 cells with CLM did not signiﬁcantly modify TG-induced Ca2+
mobilization in these cells, thus suggesting that the effect of MβCD
was speciﬁc at removing cholesterol from the cells.
3.3. Effect of MβCD on SOCE and non-capacitative Ca2+ entry
Cell treatment with TG results in passive Ca2+ efﬂux from the
intracellular stores, which results in: 1) depletion of the Ca2+ stores, and
thus, activation of SOCE, and2) elevation in [Ca2+]c,which, in turn,might
result in the activation of Ca2+-dependent signalling pathways. In
support of this, a recent study has reported that, in addition to SOCE,
treatment with TG results in autocrine stimulation of non-capacitative
Ca2+ entry in human platelets [41]. In order to investigate whether TG-
evoked Ca2+ entry in HEK293 cells is entirely capacitative we have
investigated the effect of lanthanum, awell known SOCE blocker [35,42],
on the activation and maintenance of TG-induced Ca2+ entry. As shown
in Fig. 2A, addition of 100 μM La3+, 30 min prior stimulation with TG,
abolished the entry of Ca2+ (pb0.05; n=6). Interestingly, when La3+
was added after treatmentwith TG, Ca2+ entry observed 30 min after the
addition of La3+ was signiﬁcantly reduced as compared to control
(Fig. 2B; pb0.05; n=6) but still 63% of Ca2+ inﬂux remained (Fig. 2B).
Theseﬁndings indicate that Ca2+ inﬂux inducedbybrief stimulationwith
TG is entirely capacitative while Ca2+ inﬂux observed after prolonged
stimulation with TG has both capacitative and non-capacitative
components.
Next we have investigated whether the effect of MβCD on TG-
induced activation and maintenance of Ca2+ entry was through SOCE or
through non-capacitative Ca2+ entry pathways. As expected, preincuba-
tion of HEK293 cells for 30 min at 37 °C with 10 mMMβCD in
combination with 100 μM La3+ resulted in complete inhibition of TG-
evoked Ca2+ entry when Ca2+ was reintroduced in the extracellular
medium180 s after TG (Fig. 3A). Fig. 3B shows the effect of addingMβCD
in combination with La3+ to store-depleted HEK293 cells. Either agents
or the vehicleswere added180 s after TG. AdditionofMβCDplus La3+ for
30 min reduced TG-evoked Ca2+ entry by 25% as compared to treatment
with MβCD alone, although Ca2+ entry in the presence of both agents
was still found to be signiﬁcantly greater than Ca2+ inﬂux observed in
vehicle-treated cells (TG-evokedCa2+entry in thepresenceofMβCDand
La3+ was 150% of control; pb0.05; n=6).
Fig. 3C summarizes the effects of MβCD, La3+ or a combination of
both agents on TG-induced activation and maintenance of Ca2+ entry.
Fig. 1. Effect of MβCD on the activation and maintenance of TG-induced Ca2+ entry in HEK293 cells. (A and C) fura-2-loaded cells were preincubated for 30 min at 37 °C in the
presence of 10 mMMβCD (A) or 10 mM cholesterol-loaded MβCD (CLM; C) or the vehicle (DMSO; Control). At the time of experiment, 1.2 mM EGTA was added. Cells were then
stimulated with 1 μMTG, and 180 s later 2 mMCaCl2 was added to themedium. (B and D) fura-2-loaded cells were suspended in a Ca2+-free medium (1.2 mM EGTAwas added) and
were then stimulated with 1 μM TG. Three minutes later 10 mMMβCD, 10 mM cholesterol-loaded MβCD (CLM; D) or the vehicle was added as indicated. CaCl2 (ﬁnal concentration
2 mM)was added to themedium 30 min after MβCD or CLM to initiate Ca2+ entry. Traces shown are representative of six independent experiments. (E) Total cholesterol levels were
measured from equal numbers of untreated HEK 293 cells or HEK 293 cells after treatment for 30 min with 10 mM MβCD (n=4). *pb0.05 compared to control.
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La3+ and signiﬁcantly reduced byMβCD. In contrast, the maintenance
of Ca2+ entry induced by TG was only partially sensitive to La3+ and
was facilitated by MβCD. The reduction of Ca2+ entry determined
30 min after TG induced by La3+ in the absence and presence of MβCD
was found to be similar, which strongly suggest that disruption of lipid
rafts byMβCD facilitates exclusively non-capacitative Ca2+ entry andhas
no effect on the maintenance of SOCE. To further explore this issue we
investigated the effect of MβCD on themaintenance of TG-evoked store-
operated Mn2+ entry. As shown in Table 1, treatment with MβCD once
store-operated cation entry has been activated by TG had no signiﬁcanteffect on the inﬂux of Mn2+, which further conﬁrms that lipid rafts are
not necessary for the maintenance of this process.
3.4. Role of TRPC1 and TRPC6 in the activation and maintenance of Ca2+
entry in HEK293 cells
We have now investigated the role of TRPC1 and TRPC6 in TG-
induced Ca2+ entry by using TRPC1 and TRPC6 expression silencing.
As shown in Fig. 4B and C, shTRPC1 and shTRPC6 reduced signiﬁcantly
the amount of TRPC1 and TRPC6, respectively, detected in HEK293
cells as compared to controls. Western blotting with anti-actin
Table 1
Effect of MβCD on the activation and maintenance of TG-induced Mn2+ entry.
Treatment Slope
Activation Maintenance
Control −0.0035±0.0004 −0.0026±0.0003
TG −0.0325±0.0025 −0.0278±0.0031
MβCD −0.0027±0.0002 −0.0028±0.0005
MβCD+TG −0.0229±0.0015* −0.0296±0.0033
HEK293 cells were loaded with fura-2 and resuspended in a medium containing 1 mM
Ca2+ as described in Materials and methods. Fura-2 ﬂuorescence was measured at an
excitation wavelength of 360 nm, the isoemissive wavelength. Activation: Cells were
pretreated with 10 mMMβCD or the vehicle for 30 min at 37 °C. At the time of
experiment 1.2 mM EGTA was added followed by 2 mM MnCl2 and then cells were
stimulated with TG (1 μM; TG and MβCD+TG) or the vehicle (Control and MβCD).
Maintenance: At the time of experiment 1.2 mM EGTA was added and then cells were
stimulated with TG (1 μM; TG and MβCD+TG) or the vehicle (Control and MβCD).
Three minutes later 10 mMMβCD or the vehicle was added and 30 min later 2 mM
MnCl2 was added to monitor Mn2+ entry, following the protocol described in the
legend to Fig. 1. The slopes were calculated as described under Materials and methods
(n=6). *pb0.05 compared to TG-treated cells in the absence of MβCD.
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C, bottom panels). We have found that shTRPC1 and shTRPC6 reduce
TG-induced Ca2+ entry by 38±5% and 16±4% of control, respectively
(Fig. 4A; pb0.05; n=4). A combination of shTRPC1 and shTRPC6
reduced TG-evoked Ca2+ inﬂux by 46±7% (Fig. 4A; pb0.05; n=4). As
shown in Fig. 4A, shTRPC1 and shTRPC6 did not alter TG-induced Ca2+Fig. 2. Effect of lanthanum on the activation andmaintenance of TG-induced Ca2+ entry
in HEK293 cells. (A) Fura-2-loaded cells were preincubated for 30 min at 37 °C in the
presence of 100 μMLaCl3 or the vehicle (HBS; Control) following the protocol described
in the legend to Fig. 1. At the time of experiment, 1.2 mM EGTA was added. Cells were
then stimulated with 1 μM TG, and 180 s later 2 mM CaCl2 was added to the medium.
(B) Fura-2-loaded cells were suspended in a Ca2+-free medium (1.2 mM EGTA was
added) and were then stimulated with 1 μM TG. Three minutes later 100 μM LaCl3 or
the vehicle was added as indicated. CaCl2 (ﬁnal concentration 2 mM) was added to the
medium 30 min after La3+ to initiate Ca2+ entry. Traces shown are representative of six
independent experiments.
Fig. 3. Role of lipid rafts in the activation and maintenance of TG-induced Ca2+ entry in
HEK293 cells. (A) Fura-2-loaded cells were preincubated for 30 min at 37 °C in the presence
of 100 μMLaCl3 and10 mMMβCDor thevehicles (Control) following theprotocol described
in the legend to Fig. 1. At the time of experiment, 1.2 mM EGTAwas added. Cells were then
stimulatedwith 1 μMTG, and 180 s later 2 mMCaCl2was added to themedium. (B) Fura-2-
loaded cells were suspended in a Ca2+-free medium (1.2 mM EGTA was added) and were
then stimulated with 1 μM TG. Three minutes later 100 μM LaCl3 in combination with
10 mMMβCDor thevehicleswere addedas indicated. CaCl2 (ﬁnal concentration2 mM)was
added to the medium 30min after La3+ + MβCD to initiate Ca2+ entry. Traces shown are
representativeof six independent experiments. (C)Histograms summarizing thepercentage
of Ca2+ entry in the presence of MβCD, La3+ or both relative to their control (vehicle was
added). Ca2+entrywas determined as described inMaterials andmethods. Left panel shows
the effect of preincubationwithMβCD and/or La3+ prior TG stimulation on the activation of
Ca2+ entry. Right panel shows the effect of addition of MβCD and/or La3+, to cells that had
been stimulated with TG, on the maintenance of Ca2+ entry. Values are means±SEM;
* indicates differences compared with TG-treated cells in the absence of MβCD and La3+.
ø indicates differences compared with TG-treated cells in the presence of MβCD alone.release from the intracellular stores, which indicates that this
treatment did not alter either the ability to accumulate Ca2+ in the
stores or the Ca2+ leakage rate in these cells.
We have further explored the effect of MβCD and/or La3+ on Ca2+
entry in TG-stimulated cells treated with shTRPC1 and shTRPC6
following the protocol depicted in Figs. 1B–3B. As shown in Table 2,
Fig. 4. Role of TRPC1 and TRPC6 in TG-induced Ca2+ entry. (A) HEK293 cells were
transfected with shTRPC1, shTRPC6, both or control vector (black traces) and used after
48 h for Ca2+ measurements. Cells were loaded with fura-2 and stimulated with 1 μM
TG, in a Ca2+-free medium (1.2 mM EGTA was added), followed by addition of CaCl2
(ﬁnal concentration 2 mM) to initiate Ca2+ entry. Traces are representative of four
independent experiments. (B and C) HEK293 cells were transfected with shTRPC1,
shTRPC6 or control vector, as indicated, and used after 48 h for protein detection.
Western blotting showing the expression levels of TRPC1 (B) or TRPC6 (C), which was
signiﬁcantly reduced in lysates from cells transfected with shTRPC1 or shTRPC6,
respectively. Bottom panel: Western blotting with anti-G actin antibody for protein
loading control.
1088 C. Galan et al. / Biochimica et Biophysica Acta 1803 (2010) 1083–1093both shTRPC1 and shTRPC6 signiﬁcantly reduced the Ca2+ entry evoked
by TG (pb0.05; n=3–4). shTRPC1 did not alter the La3+-insensitive
component of Ca2+ entry, while shTRPC6 attenuated this component,
thus suggesting that TRPC6, but not TRPC1, is involved in non-
capacitative Ca2+ entry in these cells (Table 2, pb0.05; n=3–4).
Interestingly, in the presence of MβCD, shTRPC1 signiﬁcantly reduced
TG-evoked Ca2+ entry in the absence but not in the presence of La3+,
which suggests that TRPC1 is involved solely in SOCE even after lipid raftTable 2
Role of TRPC1 and TRPC6 on the maintenance of TG-induced Ca2+ entry.
Treatment Integral (nM⋅s) Treatment Integral (nM⋅s)
Control 15,623±785 Control 14,923±619
shTRPC1 12,185±691⁎ shTRPC6 11,322±544⁎
MβCD 24,110±785⁎ MβCD 25,041±885⁎
shTRPC1: MβCD 20,973±705⁎ † shTRPC6: MβCD 14,009±515†
La3+ 9845±771⁎ La3+ 10,178±585⁎
shTRPC1:La3+ 9789±685⁎ shTRPC6:La3+ 6833±321⁎ †
MβCD+La3+ 19,058±744⁎ MβCD+La3+ 18,551±618⁎
shTRPC1:
MβCD+La3+
18,145±518⁎ shTRPC6:
MβCD+La3+
8925±402⁎ †
HEK293 cells were transfected with shTRPC1, shTRPC6, as indicated, or control vector
and used after 48 h for Ca2+ measurements. Fura-2-loaded cells were suspended in a
Ca2+-free medium (1.2 mM EGTA was added) and were then stimulated with 1 μM TG.
Three minutes later 100 μM LaCl3, 10 mMMβCD, both or the vehicles were added
following the protocol described in the legend to Fig. 3. CaCl2 (ﬁnal concentration
2 mM) was added to the medium 30 min after La3+ and/or MβCD to initiate Ca2+
entry. Ca2+ entry was estimated using the integral of the rise in [Ca2+]c for 150 s after
addition of CaCl2 and corrected by subtraction of the [Ca2+]c elevation due to leakage of
the indicator (n=3–4).
⁎ Pb0.05 compared to TG-treated cells in the absence of La3+ and MβCD.
† Pb0.05 compared to cells transfected with control vector.disruption. In contrast, in the presence of MβCD, shTRPC6 signiﬁcantly
reduced TG-evoked Ca2+ entry in the absence and presence of La3+. The
contribution of TRPC6 to the La3+-insensitive component was found to
be greater in the presence ofMβCD than in its absence (shTRPC6 reduced
La3+-insensitive Ca2+ entry by 33% and 52% in the absence and presence
of MβCD, respectively; Table 2). These ﬁndings suggest that MβCD
enhances the La3+-insensitive component of Ca2+ entry by recruiting
further TRPC6 channel units in the non-capacitative Ca2+ entry pathway
(Table 2, pb0.05; n=4). To conﬁrm this possibilitywe have investigated
theeffect ofMβCDonOAG-stimulatedCa2+entry.OAG is adiacylglycerol
analogue that induces non-capacitative Ca2+ entry [43]. As shown in
Fig. 5, MβCD enhanced OAG-induced Ca2+ entry by 27%. This effect was
abolished by shTRPC6 treatment, which reduced OAG-mediated Ca2+
entry per se by34% in agreementwithprevious studies reporting a role of
TRPC6 in non-capacitative Ca2+ entry [43,44]. These ﬁndings indicate
that MβCD-enhanced non-capacitative Ca2+ entry was mediated by
TRPC6.3.5. Effect of MβCD on TG-induced activation and maintenance of the
association of Orai1 with STIM1, TRPC1 and TRPC6 in HEK293 cells
We have investigated the association between the plasma mem-
brane (PM) protein Orai1 and the ER Ca2+ sensor STIM1 or the Ca2+
channel subunits TRPC1 and TRPC6 by looking for co-immunoprecip-
itation from cell lysates. Immunoprecipitation and subsequent SDS-
PAGE andWestern blottingwere conducted using resting cells and cells
treated with TG, in a Ca2+-free medium, to induce passive depletion of
the intracellular Ca2+ stores. As depicted in Fig. 6, upper panels, our
results show detectable association between Orai1 and either STIM1
(Fig. 6A), TRPC1 (Fig. 6B) and TRPC6 (Fig. 6C) in resting HEK293 cells.
Co-immunoprecipitation between Orai1 and STIM1, TRPC1 and TRPC6
was signiﬁcantly enhanced by treatment for 180 s with TG by 301, 142
and 291% of control, respectively (Fig. 6, upper panels and histograms;
pb0.05; n=6). Western blotting with anti-Orai1 antibody conﬁrmed a
similar content of this protein in all lanes (Fig. 6, middle panels).
In order to investigate the role of lipid rafts on the activation of the
interactionbetweenOrai1 and thementionedproteinswehave tested the
effect of treatment with MβCD prior stimulation with TG in a Ca2+-free
medium. As shown in Fig. 6, pretreatment for 30 min at 37 °C with
10 mMMβCD reduced TG-evoked enhanced co-immunoprecipitation
betweenOrai1 and STIM1, TRPC1 andTRPC6 stimulated by TG to 156, 122
and 145%, respectively, without having any signiﬁcant effect in the
associationbetween theseproteins in restingHEK293cells. Theseﬁndings
suggest that the associationbetweenOrai1 and theproteins STIM1, TRPC1Fig. 5. Role of TRPC6 in OAG-induced Ca2+ entry. HEK293 cells were transfected with
shTRPC6 or control vector and used after 48 h for Ca2+ measurements. Fura-2-loaded
cells were preincubated for 30 min at 37 °C in the presence of 10 mMMβCD or the
vehicle (DMSO). At the time of experiment, 2 mM CaCl2 was added. Cells were then
stimulated with 100 μM OAG. Changes in [Ca2+]c were monitored as described in
Materials and methods. Traces are representative of four separate experiments.
Fig. 6. Effect of MβCD on TG-induced activation of the association of Orai1 with STIM1, TRPC1 and TRPC6 in HEK293 cells. HEK cells were preincubated for 30 min with 10 mMMβCD
or the vehicle (DMSO) in amedium containing 1 mM Ca2+. At the time of experiment, 1.2 mM EGTAwas added. Cells were then stimulated with TG (1 μM) for 180 s or left untreated
and lysed. Whole cell lysates were immunoprecipitated (IP) with anti-STIM1 (A), anti-TRPC1 (B) or anti-TRPC6 (C) antibody and immunoprecipitates were subjected to 10% SDS-
PAGE and subsequent Western blotting with a speciﬁc anti-Orai1 antibody. Membranes were reprobed with the antibody used for immunoprecipitation for protein loading control.
The panel shows results from one experiment representative of 5 others. Molecular masses indicated on the right were determined using molecular mass markers run in the same
gel. Histograms represent the quantiﬁcation of the association of Orai1 with STIM1, TRPC1 and TRPC6 under different experimental conditions. Results are expressed as mean±SEM
and presented as percentage of control (non-stimulated cells not treated with MβCD). *pb0.05. HC, heavy chain of the immunoglobulin used for immunoprecipitation. (D) HEK cells
were preincubated for 30 min with 10 mMMβCD or the vehicle (DMSO) in a medium containing 1 mM Ca2+. Before cell stimulation 1.2 mM EGTA was added. Cells were then
stimulated with TG (1 μM), stimulation was terminated after 180 s in ice-cold Söercen's buffer, and cell surface proteins were labeled by biotinylation, as described under Materials
and methods. Labeled proteins were extracted with streptavidin-coated agarose beads and analyzed by SDS-PAGE and Western blotting (WB) using the anti-TRPC1, anti-Orai1 or
anti-TRPC6 antibody. Western blotting of the samples using anti-actin antibody was performed for sample protein controls. Positions of molecular mass markers are shown on the
right. Histograms indicate quantiﬁcation of cell surface proteins. Values are mean±SEM of four independent experiments.
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Fig. 7. Effect ofMβCDon themaintenance of the associationofOrai1with STIM1, TRPC1 and TRPC6 induced by TG inHEK293cells. HEK cellswere stimulatedwith TG (1 μM) ina Ca2+-free
medium (1.2 mM EGTA was added). Three minutes later cells were treated with 10 mMMβCD or the vehicle (DMSO) for a further 30 min and lysed. Whole cell lysates were
immunoprecipitated (IP)with anti-STIM1(A), anti-TRPC1(B) or anti-TRPC6(C) antibody and immunoprecipitateswere subjected to10%SDS-PAGEand subsequentWesternblottingwith
a speciﬁc anti-Orai1 antibody. Membranes were reprobed with the antibody used for immunoprecipitation for protein loading control. The panel shows results from one experiment
representative of 5 others. Molecular masses indicated on the right were determined using molecular mass markers run in the same gel. Histograms represent the quantiﬁcation of the
association of Orai1with STIM1, TRPC1 and TRPC6 under different experimental conditions. Results are expressed asmean±SEMand presented as percentage of control (non-stimulated
cells not treated with MβCD). *pb0.05. HC, heavy chain of the immunoglobulin used for immunoprecipitation. (D) HEK cells were stimulated with TG (1 μM) in a Ca2+-free medium
(1.2 mM EGTA was added). Three minutes later cells were treated with 10 mMMβCD or the vehicle (DMSO) for a further 30 min and stimulation was terminated in ice-cold Söercen's
buffer, and cell surface proteins were labeled by biotinylation, as described under Materials and methods. Labeled proteins were extracted with streptavidin-coated agarose beads and
analyzed by SDS-PAGE andWestern blotting (WB) using the anti-TRPC1, anti-Orai1 or anti-TRPC6 antibody.Western blotting of the samples using anti-actin antibody was performed for
sample protein controls. Positions of molecular mass markers are shown on the right. Histograms indicate quantiﬁcation of cell surface proteins. Values are mean±SEM of four
independent experiments.
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1091C. Galan et al. / Biochimica et Biophysica Acta 1803 (2010) 1083–1093andTRPC6 stimulated by short treatmentwith TG requires the integrity of
the lipid raft domains.
We have further investigated whether the changes in Ca2+ entry
or the association between Ca2+ channel proteins might be attributed
to changes in surface expression of these proteins. As shown in Fig. 6D,
analysis of biotinylated proteins shows that treatment with MβCD did
not modify surface expression of TRPC1, Orai1 or TRPC6.
Next, we have explored the co-immunoprecipitation between
Orai1 and either STIM1 or the TRPC proteins TRPC1 and TRPC6 upon
prolonged stimulation with TG (30 min treatment in a Ca2+-free
medium) to investigate the maintenance of the association between
these proteins. As shown in Fig. 7, Western blotting with anti-STIM1,
anti-TRPC1 or anti-TRPC6 antibody of anti-Orai1 immunoprecipitates
revealed association of Orai1 with STIM1, TRPC1 and TRPC6 in resting
cells. Treatment with TG (1 μM) for 30 min resulted in a small but
signiﬁcant increase in the association between Orai1 and both STIM1
and TRPC1 (after 30 min treatment with TG the association between
Orai1 and STIM1 or TRPC1 was 121 and 113% of control, respectively;
Fig. 7A and B; upper panels and histograms; pb0.05; n=6).
Interestingly, co-immunoprecipitation between Orai1 and TRPC6
was signiﬁcantly reduced after treatment for 30 min with TG to 71%
of control (Fig. 7C; upper panel and histograms; pb0.05; n=6). To
investigate the relevance of lipid raft domains on the maintenance of
the interaction between Orai1 and the mentioned proteins we have
tested the effect of treatment with MβCD on HEK293 cells that had
been stimulated with TG. As shown in Fig. 7, addition of
10 mMMβCD, 180 s after stimulation with TG, for a further 30 min
did not signiﬁcantly reduce TG-evoked co-immunoprecipitation
between Orai1 and STIM1 or TRPC1 (co-immunoprecipitation
between Orai1 and STIM1 or TRPC1 was 110 and 109% of control,
respectively), but further decreased co-immunoprecipitation be-
tween Orai1 and TRPC6 stimulated by this agent to 42% of control.
MβCD had no signiﬁcant effect in the association between these
proteins in resting HEK293 cells. As shown in Fig. 7D, treatment with
MβCD did not modify surface expression of TRPC1, Orai1 or TRPC6,
thus suggesting that the changes observed are not due to changes in
the membrane location of these proteins.
4. Discussion
A number of studies have revealed that lipid raft domains are
important for the activation of a number of cellular functions,
including cell adhesion and migration, apoptosis, organization of the
cytoskeleton, exocytosis and endocytosis [45,46]. These cellular
events are dependent on rises in [Ca2+]c and lipid rafts have been
shown to regulate the mechanism of activation of SOCE [47].
We have recently reported that activation and maintenance of
SOCE are differentially regulated in different cell types. For instance,
the activation of SOCE is sensitive to the actin cytoskeleton stabilizer
jasplakinolide, while the maintenance of Ca2+ entry is insensitive to
actin network stabilization both in human platelets and mouse
pancreatic acinar cells [3,39]. Interestingly, we now report for the ﬁrst
time that cholesterol sequestration in cells that had been pretreated
with TG enhances TG-evoked Ca2+ inﬂux.
Lipid rafts are plasma membrane domains, resistant to mild
detergents, rich in cholesterol and sphingolipids, that organize the
assembly of signalling molecules [48]. As previously demonstrated
[26] MβCD is a cholesterol-reducing agent that selectively reduces
lipid raft stability and is themostwidely usedmean to test the role of
lipid rafts. Since MβCD does not affect other lipid raft constituents,
experimental evidence suggests that, although MβCD signiﬁcantly
impair lipid rafts, it does not remove them completely. Keeping this
limitation in mind, we have investigated the role of lipid rafts in the
activation and maintenance of Ca2+ entry by addition of MβCD
either before (for the activation) or after TG stimulation (to
investigate the maintenance of SOCE), respectively. Since incuba-tionwithMβCDwasmaintained for 30 min, in order to be consistent
with the treatment with MβCD we necessarily explored the
activation and maintenance of TG-evoked Ca2+ entry at different
times after TG addition, i.e. 180 s after TG when cells were
preincubated with MβCD prior TG (for the study of the activation
process) and 30 min after TG when cells were treated with MβCD
after TG (for the study of the maintenance). We have investigated
the sensitivity of Ca2+ entry to the SOCE blocker La3+ at these time
periods and found that while Ca2+ entry after 180 s stimulationwith
TG is entirely sensitive to La3+, the inﬂux of Ca2+ after 30 min of
treatment with TG was partially insensitive to trivalent cations. The
La3+-insensitive TG-stimulated Ca2+ entry might be attributed to
the activation of cation currents through Ca2+-dependent channels
or transporters, such as the reported reverse Na+/Ca2+ exchange
activation secondary to store depletion [25]. We have found that
shTRPC6 reduces the La3+-insensitive component in these cells. A
major ﬁnding of this study is that the increase in Ca2+ entry by
addition of MβCD to TG-treated cells is mostly due to enhancement
of the La3+-insensitive component, without altering SOCE (see
Fig. 3C), thus suggesting that lipid rafts are not required for the
maintenance of SOCE once it has been activated but enhances non-
capacitative Ca2+ entry stimulated by 30 min treatment with TG, an
effect that might be attributed to the recruitment of further TRPC6
units to the non-capacitative Ca2+ entry mechanism as demon-
strated using shRNAs. Our results indicate that TRPC1 proteins
support both the activation and maintenance of SOCE stimulated by
TG and do not participate in non-capacitative Ca2+ entry upon lipid
rafts disruption in these cells. In support of the lack of effect ofMβCD
on the maintenance of SOCE we have found that incubation for
30 min with this agent after cell treatment with TG had a negligible
effect, if any, on the maintenance of Mn2+ entry. We assume that all
Mn2+ enters only through the store-operated pathway. The use of
Mn2+ to explore store-operated cation entry is widely accepted
[49]. Mn2+ avoids interferences in the study of store-operated
cation entry arising from the stimulation of the plasma membrane
Ca2+-ATPase, since Mn2+ is transported by this pump with lower
afﬁnity than Ca2+ [50,51], is a known inhibitor of the Na+/Ca2+
exchanger [52] and the permeability for Mn2+ of non-capacitative
Ca2+-selective channels, such as TRPV6, is signiﬁcantly smaller than
for Ca2+ [53].
Lipid raft domains have been reported to provide an adequate
environment for the interaction of different SOCE-associated proteins,
including STIM1, Orai1 and TRPC proteins [27,28,47], although the role of
lipid rafts in the activation of SOCE and the association of STIM1 andOrai1
with lipid rafts has been recently challenged by a recent report suggesting
that ICRAC is not dependent on lipid raft domains [54]. Our results indicate
that lipid rafts play a relevant role in the activation but not the
maintenance of the association of Orai1 with the ER Ca2+ sensor STIM1
and the channel subunit TRPC1 stimulated by TG. We noticed that TG-
evokedassociationbetween theseproteinswas transient and30 minafter
TG addition the interaction between these proteins was close to the
resting level. Interestingly, we found that TG promotes and initial
association between Orai1 and TRPC6 but prolonged stimulation with
TGresults indissociationof theseproteins.Wehave recently reported that
TRPC6participates both in SOCE andnon-capacitative Ca2+ entry through
its interactionwith theOrai1-STIM1 complex or hTRPC3 respectively [22].
Althoughwehavenot investigated the associationof TRPC6withTRPC3 in
this study, dissociation of TRPC6 fromOrai1might underlie the activation
of non-capacitative Ca2+ entry. This would provide an explanation to the
effectsofMβCDbothenhancingnon-capacitativeCa2+entryandreducing
co-immunoprecipitation of Orai1 with TRPC6.
In conclusion, our results indicate that lipid rafts play an important
role in TG-induced divalent cation entry, which is likely mediated by a
role of lipid rafts in the association between Orai1, the ER Ca2+ sensor
STIM1 and the channel subunits TRPC1 and TRPC6. Lipid rafts
disruption before the activation of SOCE results in attenuation of
1092 C. Galan et al. / Biochimica et Biophysica Acta 1803 (2010) 1083–1093store-operated association between these proteins and cation entry;
however, when disruption of lipid rafts occurs after store depletion
the association of Orai1 with STIM1 or TRPC1 was not signiﬁcantly
reduced, as well as Mn2+ entry, but dissociation between Orai1 and
TRPC6 was clearly enhanced, thus explaining the increased non-
capacitative Ca2+ entry.
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